Clinical trial · Observational
Management of Mixed-Phenotype Acute Leukemia in the East of France
NCT03599869CI-TRIAL-00033969ELABESTunknownClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Clinical presentation and management of Mixed-Phenotype Acute leukemia (MPAL) is heterogeneous. This descriptive observationnal study aims to review MPAL cases in the East of France based on a 10-year multicentre retrospective collection.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Mixed Phenotype Acute Leukemia | Mixed Phenotype Acute Leukemia | ONTOLOGY_EXACT | 0.98 |
Interventions
Interventions (0)
Data not yet available
No intervention recorded.
Design
Arms and outcomes
Arms (0)
[]Primary outcomes (20)
- measure
- Age of the patients when diagnosed with MPAL
- timeFrame
- At inclusion (Day 0)
- description
- Age in years
- measure
- Sex of the patients when diagnosed with MPAL
- timeFrame
- At inclusion (Day 0)
- description
- Male or female
- measure
- City of the hematology unit in charge of each patient for the treatment of MPAL
- timeFrame
- At inclusion (Day 0)
- description
- Nancy, Metz-Thionville, Reims, Strasbourg, Mulhouse, Dijon or Besançon
- measure
- MPAL rate in the each hematology unit
- timeFrame
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Adult patients over 18 years of age * Diagnosis of biphenotypic acute leukemia or mixed-phenotype acute leukemia between 2008 and 2018
References
Publications (0)
Data not yet available
No reference posted for this study.